IP Verse

Df Mp Drries Frank Molnia & Pohlman competitive analysis

Latest oppositions filed by Df Mp Drries Frank Molnia & Pohlman

Explore patent oppositions filed by Df Mp Drries Frank Molnia & Pohlman against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 25, 2026
Patent NumberTitleApplicantOpposition Date
EP3600806
Transparent Wood And A Method For Its PreparationCELLUTECHMar 7, 2024
EP2234617
Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICADec 23, 2021
EP3461484
Combination TherapyAERIE PHARMACEUTICALSAug 18, 2021
EP3068403
Methods Of Treatment Of Ocular Conditions With A Sustained Drug Delivery ImplantALLERGANMar 16, 2021
EP3280416
Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICAJan 22, 2021
EP3215173
Glycopeptide CompositionsXELLIA PHARMACEUTICALS APSOct 1, 2020
EP3027174
Pharmaceutical Compositions Of FingolimodAIZANT DRUG RESEARCH SOLUTIONS PRIVATEApr 24, 2020
EP2439273
Human Monoclonal Antibodies To Programmed Death 1(Pd-1) And Methods For Treating Cancer Using Anti-Pd-1 Antibodies Alone Or In Combination With Other ImmunotherapeuticsE R SQUIBB & SONSNov 27, 2019
EP2760929
Tyre With Improved Grip On Wet GroundCOMPAGNIE GNRALE DES ETABLISSEMENTS MICHELINApr 30, 2019
EP3401400
Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of TranscriptionCHARPENTIERApr 4, 2019

Latest PTAB cases involving Df Mp Drries Frank Molnia & Pohlman

Discover the latest PTAB cases involving Df Mp Drries Frank Molnia & Pohlman, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Df Mp Drries Frank Molnia & Pohlman with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 25, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
DF MP DRRIES FRANK MOLNIA & POHLMAN13 - - -
CHARPENTIER - 23 - -
GENENTECH - 122 - 66
JANSSEN PHARMACEUTICA175 - 1